Literature DB >> 20019337

Serial OX40 engagement on CD4+ T cells and natural killer T cells causes allergic airway inflammation.

Triya Damayanti1, Toshiaki Kikuchi, Jamal Zaini, Hisayoshi Daito, Masahiko Kanehira, Kazuyoshi Kohu, Naoto Ishii, Masanobu Satake, Kazuo Sugamura, Toshihiro Nukiwa.   

Abstract

RATIONALE: OX40-OX40 ligand (OX40L) interactions have been proposed to support induction of allergic airway inflammation, which may be attributable to OX40 signaling in CD4(+) helper T cells for adaptive immune responses. However, a possible involvement of natural killer T (NKT) cells in the pathogenesis suggests that the underlying mechanisms are not yet fully elucidated.
OBJECTIVES: We aimed to characterize the OX40-modulated cellular contribution to allergic airway inflammation in a mouse model of house dust mite (HDM) allergen exposure.
METHODS: Mice were sensitized to HDM and, 3 weeks later, challenged with HDM on three consecutive days through the airways. Two days after the last exposure, bronchoalveolar lavage fluids and blood samples and lung tissues were evaluated for the airway inflammation.
MEASUREMENTS AND MAIN RESULTS: The development of HDM-induced eosinophilic airway inflammation was dependent on OX40 of both CD4(+) T cells and NKT cells; OX40 engagement on CD4(+) T cells in the sensitization led to pulmonary OX40L augmentation after the allergen challenge, which stimulated pulmonary NKT cells through OX40 to provide the pathogenic cytokine milieu. This was ablated by OX40L blockade by inhalation of the neutralizing antibody during the challenge, suggesting the therapeutic potential of targeting pulmonary OX40-OX40L interactions. Moreover, OX40 expression in CD4(+) T cells, but not in NKT cells, was reciprocally regulated by the helper T cell type 1-skewing transcription factor Runx3.
CONCLUSIONS: OX40 on not only CD4(+) T cells but also NKT cells is involved in allergic airway inflammation. Notably, pulmonary blockade of OX40 ligation on NKT cells has therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019337     DOI: 10.1164/rccm.200910-1598OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  11 in total

1.  Update in asthma 2010.

Authors:  Shamsah Kazani; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2011-08-01       Impact factor: 21.405

2.  Innate signals from Nod2 block respiratory tolerance and program T(H)2-driven allergic inflammation.

Authors:  Wei Duan; Amit K Mehta; Joao G Magalhaes; Steven F Ziegler; Chen Dong; Dana J Philpott; Michael Croft
Journal:  J Allergy Clin Immunol       Date:  2010-11-04       Impact factor: 10.793

Review 3.  NKT cell costimulation: experimental progress and therapeutic promise.

Authors:  Marianne J van den Heuvel; Nitan Garg; Luc Van Kaer; S M Mansour Haeryfar
Journal:  Trends Mol Med       Date:  2010-11-17       Impact factor: 11.951

4.  MicroRNA-19a Inhibition Directly and Indirectly Ameliorates Th2 Airway Inflammation in Asthma by Targeting RUNX3.

Authors:  Shaojun He; Jingrun Zhou; Ying Ma; Wei Wang; Jiong Yang
Journal:  Inflammation       Date:  2022-09-16       Impact factor: 4.657

5.  TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury.

Authors:  Peixiang Lan; Yihui Fan; Yue Zhao; Xiaohua Lou; Howard P Monsour; Xiaolong Zhang; Yongwon Choi; Yaling Dou; Naoto Ishii; Rafik M Ghobrial; Xiang Xiao; Xian Chang Li
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

6.  Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation.

Authors:  Fengyang Lei; Jianyong Song; Rizwanul Haque; Xiaofang Xiong; Deyu Fang; Yuzhang Wu; Susanne M A Lens; Michael Croft; Jianxun Song
Journal:  Eur J Immunol       Date:  2013-05-28       Impact factor: 5.532

7.  Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model.

Authors:  Jonathan Nambiar; Adam W Clarke; Doris Shim; David Mabon; Chen Tian; Karolina Windloch; Chris Buhmann; Beau Corazon; Matilda Lindgren; Matthew Pollard; Teresa Domagala; Lynn Poulton; Anthony G Doyle
Journal:  MAbs       Date:  2015       Impact factor: 5.857

8.  NKT cells contribute to basal IL-4 production but are not required to induce experimental asthma.

Authors:  Christopher G McKnight; Suzanne C Morris; Charles Perkins; Zhenqi Zhu; David A Hildeman; Albert Bendelac; Fred D Finkelman
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

9.  OX40 ligand newly expressed on bronchiolar progenitors mediates influenza infection and further exacerbates pneumonia.

Authors:  Taizou Hirano; Toshiaki Kikuchi; Naoki Tode; Arif Santoso; Mitsuhiro Yamada; Yoshiya Mitsuhashi; Riyo Komatsu; Takeshi Kawabe; Takeshi Tanimoto; Naoto Ishii; Yuetsu Tanaka; Hidekazu Nishimura; Toshihiro Nukiwa; Akira Watanabe; Masakazu Ichinose
Journal:  EMBO Mol Med       Date:  2016-04-01       Impact factor: 12.137

10.  Syndecan 4 Mediates Nrf2-dependent Expansion of Bronchiolar Progenitors That Protect Against Lung Inflammation.

Authors:  Arif Santoso; Toshiaki Kikuchi; Naoki Tode; Taizou Hirano; Riyo Komatsu; Triya Damayanti; Hozumi Motohashi; Masayuki Yamamoto; Tetsuhito Kojima; Toshimitsu Uede; Toshihiro Nukiwa; Masakazu Ichinose
Journal:  Mol Ther       Date:  2015-08-26       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.